Results 31 to 40 of about 75,611 (308)

blaKPC gene Detection in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae in a Tertiary Care Hospital [PDF]

Journal of Clinical and Diagnostic Research, 2013
Introduction: Carbapenem resistance among Enterobacteriaceae, especially in Klebsiella pneumoniae and Escherichia coli, is an emerging problem worldwide.
Priyadarshini Shanmugam, Jeya Meenakshisundaram, Perumal Jayaraman   +2 more
doaj   +1 more source

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects [PDF]

Frontiers in Microbiology, 2018
Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control. Many investigations have shown a high association of CRE infections with high case-fatality rates.
Shio-Shin Jean, Shio-Shin Jean, Nan-Yao Lee, Hung-Jen Tang, Hung-Jen Tang, Min-Chi Lu, Wen-Chien Ko, Po-Ren Hsueh, Po-Ren Hsueh   +8 more
openaire   +4 more sources

Frequency of High Antimicrobial Susceptibility Carbapenemase Producing Enterobacteriaceae in Clinical Isolates of a Set of Population

Journal of Rawalpindi Medical College, 2022
Objective: The objective of the study was to determine the frequency and antimicrobial susceptibility pattern of Carbapenem-Resistant Enterobacteriaceae among clinical isolates in Karachi, Pakistan.
Faisal Iqbal Afridi, Saeeda Baig, Aliya Irshad Sani, Qamar Jamal
doaj   +1 more source

Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Int J Mol Sci
Bucataru A, Turcu-Stiolica A, Calina D, Balasoiu AT, Zlatian OM, Osman A, Balasoiu M, Ghenea AE.   +7 more
europepmc   +2 more sources

European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria [PDF]

, 2020
Background Antimicrobial resistance (AMR) compromises the treatment of patients with serious infections in intensive care units (ICUs), and intensive care physicians are increasingly facing patients with bacterial infections with limited or no adequate ...
De Waele, Jan, Friggeri, Arnaud, Garnacho-Montero, José, Gustin, Marie Paule, Jean, Astrid, Kohlenberg, Anke, Lepape, Alain, Monnet, Dominique L., Savey, Anne, Vanhems, Philippe   +9 more
core   +2 more sources

Environmental Contamination by Carbapenem-Resistant Enterobacteriaceae [PDF]

Journal of Clinical Microbiology, 2013
ABSTRACT In the last decade, the global emergence of carbapenem resistance in Enterobacteriaceae has posed great concern to public health. Data concerning the role of environmental contamination in the dissemination of carbapenem-resistant Enterobacteriaceae (CRE) are currently ...
Lerner, A., Adler, A., Abu-Hanna, J., Meitus, I., Navon-Venezia, S., Carmeli, Y.   +5 more
openaire   +2 more sources

Carbapenem-resistant enterobacteriaceae: don’t trust your neighbour [PDF]

European Journal of Public Health, 2020
Abstract Background The spread of carbapenem-resistant enterobacteriaceae (CRE) outbreaks consists not only of germs producing KPC and OXA-48, endemic already, but also metallo-beta-lactamase such as NDM or VIM.
Cuccaro, C, Tarroni, M, Tinturini, A, Cresti, S, Basagni, C, Nante, N, Messina, G, De Marco, MF   +7 more
openaire   +2 more sources

A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options

Future Science OA, 2020
Carbapenems are a class of antimicrobial agents reserved for infections caused by multidrug-resistant microorganisms. The emergence of carbapenem resistance has become a serious public health threat.
Ann A Elshamy, Khaled M Aboshanab
doaj   +1 more source

Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections

Antimicrobial Agents and Chemotherapy, 2020
The comparative efficacy of ceftazidime-avibactam and meropenem-vaborbactam for treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections remains unknown.
Renee Ackley, Danya Roshdy, Jacqueline Meredith, S. Minor, W. Anderson, G. Capraro, C. Polk   +6 more
semanticscholar   +1 more source

Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: Combined susceptibility of eravacycline.

Journal of Global Antimicrobial Resistance, 2022
OBJECTIVE This study aimed to investigate the synergistic activity of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii collected from China.
Yun Li, Lanqing Cui, F. Xue, Qing Wang, B. Zheng   +4 more
semanticscholar   +1 more source